Article NEJM Audio Interview Interview with Dr. Tait Shanafelt on causes of burnout and efforts to improve support for clinicians. (13:21) Download In late 2016, a primary care physician with a thriving practice decided it was time to shut her doors. She felt her retirement was forced on her after she’d spent a year in the grips of her health care system’s new electronic health record (EHR). It was her fourth EHR over her years of doctoring, but this transition felt different. Instead of improving her efficiency, the new system took time away from her patients, added hours of clerical work to each day, and supplanted her clinical judgment with the government’s metrics for “meaningful use” of information technology in health care. “We’re spending our days doing the wrong work,” argues Christine Sinsky, a practicing internist and vice president for professional satisfaction at the American Medical Association, who has conducted several studies tracking how doctors spend ...
Entradas populares de este blog
Artificial Intelligence Trump’s Treasury Secretary Says Increased Automation Is “Not Even on Our Radar” During his campaign, now-President Donald Trump promised voters he would bring American jobs back from overseas. Now that he is in office, his administration has made job creation a central focus of its efforts. But what if those jobs overseas can’t come back to the United States because companies no longer need to hire humans to complete the tasks? How is the Trump administration gearing up to tackle the rise of automation Based on recent statements by Trump’s Treasury Secretary, Steven Mnuchin, they aren’t planning to address it all. In a conversation with Axios co-founder Mike Allen, Mnuchin said that increased automation is “not even on our radar screen” as the problem is “50 to 100 more years away.” He continued, saying, “I’m not worried at all. In fact, I’m optimistic.” THEY’RE NOT COMING BACK The administration’s claims run counter to the mounting evidenc...
ORIGINAL ARTICLE Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab List of authors. Anil Gupta, M.D., Yaneicy Gonzalez-Rojas, M.D., Erick Juarez, M.D., Manuel Crespo Casal, M.D., et al., for the COMET-ICE Investigators * October 27, 2021 DOI: 10.1056/NEJMoa2107934 Article Figures/Media Metrics 27 References Abstract BACKGROUND Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibody that was designed to prevent progression of Covid-19 in high-risk patients early in the course of disease. METHODS In this ongoing, multicenter, double-blind, phase 3 trial, we randomly assigned, in a 1:1 ratio, nonhospitalized patients with symptomatic Covid-19 (≤5 days after the onset of symptoms) and at least one risk factor for disease progression to receive a single infusion of sotrovimab at a...
Comentarios
Publicar un comentario